More News! 9 Oct 2019 Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing The Danish big pharma Novo Nordisk has joined forces with the US gene therapy company bluebird bio to develop next-generation gene editing treatments for hemophilia. The collaboration will last for three years and has the goal of developing a gene therapy that can permanently treat hemophilia A, a genetic disease causing uncontrolled bleeding. Novo Nordisk […] October 9, 2019 - 1 minutemin - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 8 Oct 2019 UK Company and Merck Team Up to Develop Vaccines Based on the Microbiome Merck will pay the microbiome company 4D Pharma up to €316.5M to develop vaccines based on delivering live bacteria to the gut. The partners will develop vaccines against three undisclosed conditions. As well as an undisclosed upfront fee for each condition, 4D Pharma will be eligible to receive up to €316.5M ($347.5M) in developmental milestones. […] October 8, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 8 Oct 2019 Biotech Hubs: A Tale of Two Cities Life science investors differ widely across biotech hubs in Europe. At Labiotech’s recent Refresh event, two investors from Cambridge and Paris compared the progress of these hubs and discussed the challenges that need to be overcome in biotech investment. Funding is the lifeblood of early biotech startups, and investors are a crucial supplier. For this […] October 8, 2019 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 8 Oct 2019 Israeli Biotech 3D Prints the First Beef Steak in Space Hungry astronauts rejoice! Aleph Farms, a company that grows beef steak from animal cells, has grown the first steaks aboard the International Space Station. The Israeli biotech’s experiment is the first proof that meat can be grown in outer space. Aleph Farms created the meat using a 3D bioprinter developed by the Russian company 3D […] October 8, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Expert Advice 8 Oct 2019 Why Good Teamwork is Key to Biotech Success Teamwork is important throughout the development of a company, but never more so than in the early stages of a startup. Charlotte Edenius, co-founder and VP Business and Clinical development at Gesynta Pharma in Sweden, knows this well. With more than 20 years experience working in the industry, she knows how important it is for biotech leaders […] October 8, 2019 - 10 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
More News! 7 Oct 2019 UK Biotech Launches with €30M Series A to Treat Autoimmune Disease MiroBio has spun out of the University of Oxford with a Series A round of €30M (£27M) to develop treatments for autoimmune diseases that don’t disrupt the immune system as a whole. The big Series A round accompanying MiroBio’s launch was co-led by the university’s investor partner Oxford Sciences Innovation and the US investor Samsara […] October 7, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 4 Oct 2019 This Biotech Genetically Engineers Trees to Produce Biofuels The Swedish company SweTree Technologies is developing genetically engineered trees as environmentally friendly alternative sources of fuel. Mission: To improve the yield and robustness of tree crops such as spruce and eucalyptus using selective breeding and genetic engineering. This would help to boost the production of products such as biofuels and wood from each tree. […] October 4, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Oct 2019 ADC Therapeutics Cancels Nasdaq IPO Amidst Market Growth Fears The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO, citing adverse market conditions caused by global manufacturing slowdowns. ADC Therapeutics declined to comment on the specific market situation. Its withdrawal is likely due to slumps in European and US stock markets seen earlier this week caused by drops in […] October 4, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 2 Oct 2019 Engineered Crop Plants Produce Fat Molecules for Formula Milk A team from the Rothamsted Research center, UK, has developed plants capable of mass-producing fat molecules resembling those in human breast milk. The scientists modified the way a type of oilseed plant generates fat molecules by introducing a mutation that changed the location within the cell of an enzyme responsible for processing fat. As a […] October 2, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 2 Oct 2019 RNA Therapies, Immunotherapies and Cancer Tests Showcased in Spain Biotech companies around the world gathered in Barcelona, Spain, to present breakthroughs in cancer diagnostics and treatments such as cell therapies and cancer vaccines. Here’s our take on the most interesting offerings from the European crop. Barcelona is the home of Gaudi and Barcelona Football Club. Over the last few days, it was also the […] October 2, 2019 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Opinion 30 Sep 2019 Can European Biotech Companies Afford Not to Work with China? In the current trade standoff between the US and China, Europe has a golden opportunity to gain a competitive advantage. At every healthcare conference I’ve been to recently in the US or Europe, the same question is being debated on panels: Should you or should you not have a China strategy as a biotech CEO? […] September 30, 2019 - 4 minutesmins - By Antoine Papiernik Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2019 Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin treatment development deal has finished with mixed results for Adocia. Eli Lilly has now paid €13M to Adocia, after the US Arbitration Association Panel supported Adocia’s claim last year. The payment consists of a milestone payment of €10.1M plus interest. […] September 30, 2019 - 4 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email